CSRT.L Share News (CSRT)

CSRT.L Information

There is currently no data for CSRT

Consort Medical Signs VapourSoft Development Agreement With Regeneron

Fri, 18th Oct 2019 08:13

(Alliance News) - Consort Medical PLC on Friday said it has signed a contract with Regeneron Pharmaceuticals Inc, a biopharmaceutical company, to develop VapourSoft.

VapourSoft facilitates delivery of a broad range of drug formulations through the use of a liquid gas propellant.

The inhalation devices manufacturer said its proprietary VapourSoft technology will be incorporated into a novel drug delivery device designed by Regeneron.

If Regeneron elects to commercialise the developed device, Consort Medical said the parties will enter into a full commercial supply agreement with manufacturing to be undertaken by Consort for both the VapourSoft technology and the drug delivery device.

"We are delighted to be working with such a leading biotechnology innovator as Regeneron to develop novel devices for injectable drug delivery," said Consort Medical Chief Executive Jonathan Glenn.

"The agreement recognises the wide applicability of the VapourSoft technology as a power source for auto-injectors and the potential for incorporation into devices where conventional spring-based systems may not be suitable," added Glenn.

Consort Medical shares were trading 4.0% higher on Friday in London at 780.00 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

More News

3 Feb 2014 10:50

Consort Medical Gets US FDA Approval For Auto-Injector

LONDON (Alliance News) - Consort Medical PLC said Monday that it had received approval from the US Food and Drug Administration for its auto-injector programme INJ300. The company said that it expects to launch the auto-injector product in the first quarter of 2014, ahead of its previous ex

3 Feb 2014 10:06

UK BROKER RATINGS: Deutsche Bank Cuts ARM To Hold From Buy

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
JEFFERIES CUTS WEIR GROUP PRICE TARGET TO 2335 (2500) PENCE - 'HOLD'
----------
SOCGEN INITIATES ITV WITH 'HOLD' - TA

3 Feb 2014 09:18

Monday broker round-up UPDATE

Advanced Computer Software: Panmure Gordon shifts target price from 132p to 139p and keeps a buy recommendation. AGA Rangemanager: Canaccord Genuity initiates with a target price of 300p and a buy recommendation. Avon Rubber: Canaccord Genuity initiates with a target price of 720p and a hold recom

15 Jan 2014 06:26

UK Dividends Calendar - Week Ahead

14 Jan 2014 16:02

UK Dividends Calendar - Week Ahead

4 Dec 2013 09:50

Solid first half for Consort Medical as pipeline advances

Solid first half results from Consort Medical were in line with analyst forecasts as the group remained on track for the full year and with its medium-term projects. The FTSE Smallcap company divided its revenues for the first time into three categories: Respiratory - MDI (Metered Dose Inhalers),

4 Dec 2013 09:21

Wednesday broker round-up UPDATE

Afren: FinnCap lowers target price from 170p to 165p and downgrades to hold. Amlin: Espirito Santo upgrades to buy with a target price of 509p. Betfair: Citi raises target price from 1150p to 1225p maintaining a buy recommendation. Brewin Dolphin: Canaccord Genuity increases target price from 285

3 Dec 2013 15:14

Sector movers: Healthcare stocks gain, Smith & Nephew hits record high

A reduction in risk appetite across financial markets on Tuesday helped stocks in defensive sectors such as healthcare with heavyweight constituent Smith & Nephew lifted higher after a broker upgrade. Sectors such as mining, oil and banking were being sold off today with "risk assets [being] dumped

28 Nov 2013 10:30

Consort Medical Wins Inhaler Manufacturing Deal With Big Pharma Client

28 Nov 2013 09:19

Consort wins contract for potential blockbuster

Drug delivery specialist Consort Medical has won a multi-year deal to supply a dry powder inhaler that will require significant expansion of its manufacturing facilities. The DEV610 inhaler, which is in the FTSE Smallcap company's development pipeline, has been signed up by an as-yet-unnamed global

27 Sep 2013 16:11

Hiscox and Restaurant Group CEOs sell up

Chief Executive at Hiscox, Bronek Masojada, has sold 10,000 shares at 650.50p a piece in the insurance provider. The sale generated £65,050 for Masojada, who joined the company in 1993. For the first half of the year the group posted a pre-tax profit of £180.7m (2012: £125.8m), helped by low ex

5 Sep 2013 16:11

LSL Chief sells four million shares ahead of role change

Simon Embley, the out-going Chief Executive of LSL Property, announced plans to sell just short of 20m pounds-worth of shares in the residential property services provider. Embley, who is changing roles within the company to Deputy Chairman on September 9th, traded in a total of 4.16m shares at an

5 Sep 2013 13:06

DIRECTOR DEALINGS - Consort Medical Executives Sell Vested Shares

11 Jul 2013 08:23

Thursday broker round-up UPDATE

Afren: JP Morgan reduces target price from 195p to 165p and downgrades to underweight. Associated British Foods: Panmure Gordon increases target price from 1800p to 2100p upgrading from hold to buy. AVEVA Group: JP Morgan ups target price from 2300p to 2430p and retains a neutral rating. Aviva: M

9 Jul 2013 07:53

Tuesday broker round-up UPDATE

Adept Telecom: Northland Capital revises target price from 108p to 115p and maintains a buy recommendation. AG Barr: Panmure Gordon raises target price from 500p to 600p and retains a hold recommendation. Aquarius Platinum: Westhouse Securities shifts target price from 35p to 40p upgrading from se

Latest Share Chat

CSRT.L Share News (CSRT)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consort Medical Signs VapourSoft Development Agreement With Regeneron

Login to your account

Quickpicks are a member only feature

Login to your account